House Dust Mite Allergy Clinical Trial
Official title:
Multicenter Study for Evaluation of Efficacy and Safety of Perennial Specific Immunotherapy With a Depot House Dust Mite Allergen Extract (D. Pteronyssinus 100%) in Patients With House Dust Mite Sensitivity
The trial is performed to assess efficacy and safety of Novo-Helisen Depot in allergic Rhinoconjunctivitis
n/a
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02443805 -
Efficacy & Safety of STG320 Sublingual Tablets of HDM Allergen Extracts in Adults and Adolescents With HDM-associated AR
|
Phase 3 | |
| Completed |
NCT03094845 -
Safety and Clinical Tolerability of hdmASIT+TM Peptides Administered in HDM-induced Allergic Patients
|
Phase 2 | |
| Completed |
NCT01930461 -
Dose Ranging Study of SLIT Tablets of House Dust Mite Allergen Extracts (HDM) in Adults With HDM-associated Allergic Asthma
|
Phase 2 | |
| Completed |
NCT01923792 -
ToleroMune House Dust Mite Follow on Study
|
N/A | |
| Completed |
NCT00574704 -
A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
|
Phase 2 | |
| Completed |
NCT05019209 -
Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis Patients
|
N/A | |
| Recruiting |
NCT02238353 -
AZELASTINE/FLUTICASONE (AZE/FLU) Nasal Spray on Symptom Control, Nasal Mediators and Nasal Hyperresponsiveness in Allergic Rhinitis (AR)
|
Phase 4 | |
| Completed |
NCT01454544 -
A One Year Trial Evaluating the Safety and Efficacy of the ALK House Dust Mite Allergy Tablet
|
Phase 3 | |
| Terminated |
NCT01777464 -
Role of the Central Nervous System in Allergic Rhinitis
|
N/A | |
| Completed |
NCT00574223 -
A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis
|
Phase 2 | |
| Completed |
NCT02345278 -
SUBLIVAC FIX Mite Mixture Dose Tolerability Study
|
Phase 1/Phase 2 | |
| Completed |
NCT01608243 -
Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts
|
Phase 1 | |
| Completed |
NCT04435678 -
Diagnostic Accuracy of the MADx Multi Array Xplorer (MAX 45k) Automated Laboratory System and the MADx Allergy Explorer Version 2 (ALEX²) - IgE Multiplex Test for the Diagnosis of Pre-defined Groups of Specific High-priority Allergens
|
N/A | |
| Completed |
NCT01134757 -
Safety of Bronchial Allergen Challenge and Predictors for Positive Reaction.
|
N/A | |
| Recruiting |
NCT05395689 -
Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM
|
Phase 3 | |
| Not yet recruiting |
NCT05400811 -
Efficacy and Safety Evaluation for the Treatment of HDM Induced Allergic Asthma and Rhinitis/Rhinoconjunctivitis
|
Phase 3 | |
| Not yet recruiting |
NCT05450289 -
The Efficacy of Nigella Sativa in Children With House Dust Mite-Induced Respiratory Allergy Receiving Immunotherapy
|
N/A | |
| Recruiting |
NCT05174689 -
Epigenetic Regulation of Exercise Induced Asthma
|
N/A | |
| Terminated |
NCT04874714 -
Efficacy and Safety Evaluation for the Treatment of Asthma and Allergic Rhinitis/Rhinoconjunctivitis
|
Phase 3 | |
| Completed |
NCT00380926 -
Fish Oil and Asthma in House Dust Mite Allergy
|
Phase 2/Phase 3 |